Sanofi announces agreement for potential first-in-class vaccine against extraintestinal pathogenic E. coli
STADA further grows European Consumer Healthcare portfolio | STADA
Download the press release dated April 12, 2011 - Sanofi
Press Release
Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the
Sanofi announces Paris 2024 Premium partnership for the Olympic and Paralympic Games in Paris
Sanofi sur LinkedIn : Sanofi offers to acquire Kiadis Pharma, a clinical-stage company… | 19 commentaires
Sanofi on LinkedIn: Press Release: Sanofi announces agreement for potential first-in-class… | 47 comments
Press Release
Pavel Senin on LinkedIn: Press Release: Sanofi delivers first medicines from Global Health Unit's…
Press Release
Press Release
Communiqué de presse : Sanofi dévoile sa nouvelle marque et son nouveau logo, et se fédère autour d'une vocation et d'une identité unique - Sanofi
PDF - Paris2024-Press Release - Sanofi announces Paris 2024 Premium partnership for the Olympic and Paralympic Games in Paris.pdf
2019 Capital Markets Day - Press Release
Press Release - Sanofi moves forward with EUROAPI listing on Euronext Paris
Press Release
Sanofi on X: "We are excited to announce that Sanofi will be the premium partner of the @Paris2024 Olympic and Paralympic Games! Read the news: https://t.co/K2Efyo03wq https://t.co/O0ECBaireW" / X
Nancy Whiting on LinkedIn: Recludix Pharma Enters into a Strategic Collaboration with Sanofi to… | 20 comments
Communiqué de presse : Sanofi entame un nouveau chapitre de sa stratégie Play to Win
